Aouri, M.; Moradpour, D.; Cavassini, M.; Mercier, T.; Buclin, T.; Csajka, C.; Telenti, A.; Rauch, Andri; Decosterd, L. A. (2013). Multiplex Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Therapeutic Drug Monitoring of Ribavirin, Boceprevir, and Telaprevir. Antimicrobial agents and chemotherapy, 57(7), pp. 3147-3158. American Society for Microbiology 10.1128/AAC.00281-13
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
zac3147.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) |
New directly acting antivirals (DAAs) that inhibit hepatitis C virus (HCV) replication are increasingly used for the treatment of chronic hepatitis C. A marked pharmacokinetic variability and a high potential for drug-drug interactions between DAAs and numerous drug classes have been identified. In addition, ribavirin (RBV), commonly associated with hemolytic anemia, often requires dose adjustment, advocating for therapeutic drug monitoring (TDM) in patients under combined antiviral therapy. However, an assay for the simultaneous analysis of RBV and DAAs constitutes an analytical challenge because of the large differences in polarity among these drugs, ranging from hydrophilic (RBV) to highly lipophilic (telaprevir [TVR]). Moreover, TVR is characterized by erratic behavior on standard octadecyl-based reversed-phase column chromatography and must be separated from VRT-127394, its inactive C-21 epimer metabolite. We have developed a convenient assay employing simple plasma protein precipitation, followed by high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) for the simultaneous determination of levels of RBV, boceprevir, and TVR, as well as its metabolite VRT-127394, in plasma. This new, simple, rapid, and robust HPLC-MS/MS assay offers an efficient method of real-time TDM aimed at maximizing efficacy while minimizing the toxicity of antiviral therapy.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Rauch, Andri |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0066-4804 |
Publisher: |
American Society for Microbiology |
Language: |
English |
Submitter: |
Annelies Luginbühl |
Date Deposited: |
21 Mar 2014 11:33 |
Last Modified: |
05 Dec 2022 14:29 |
Publisher DOI: |
10.1128/AAC.00281-13 |
BORIS DOI: |
10.7892/boris.44330 |
URI: |
https://boris.unibe.ch/id/eprint/44330 |
Actions (login required)
 |
Edit item |